sizofiran has been researched along with Cystadenocarcinoma, Mucinous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohara, N; Teramoto, K | 1 |
| Adachi, T; Hoshino, T; Suzuki, Y; Takayama, M; Takeichi, M | 1 |
1 trial(s) available for sizofiran and Cystadenocarcinoma, Mucinous
| Article | Year |
|---|---|
[Combined effects of sizofiran and rG-CSF on myelosuppression in cancer chemotherapy].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Recombinant Proteins; Sizofiran; Thrombocytopenia | 1996 |
1 other study(ies) available for sizofiran and Cystadenocarcinoma, Mucinous
| Article | Year |
|---|---|
Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Doxorubicin; Female; Glucose Solution, Hypertonic; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Sizofiran; Treatment Outcome | 2002 |